-+ 0.00%
-+ 0.00%
-+ 0.00%

Zoetis Publishes Q3 2026 Earnings Call Transcript

PUBT·11/06/2026 14:52:10
Zoetis Publishes Q3 2026 Earnings Call Transcript
  • Zoetis narrowed 2026 revenue guidance to $9.22 billion-$9.32 billion, raising adjusted diluted EPS guidance to $6.25-$6.35.
  • CEO Kristin Peck, CFO and COO James Saccaro attended the November 5 third-quarter earnings call with corporate finance chief Mathieu Aussermeier.
  • Quarterly revenue fell 1% to $2.4 billion; adjusted net income declined 7% on an organic operational basis to $720 million.
  • Dermatology sales dropped 16% to $396 million as competition weighed; promotions slowed US share losses to 4 points from 7 points.
  • Management expects competitive pressures through most of 2027, assumes no macroeconomic improvement and anticipates limited revenue contributions from new launches.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.